Ingebrigt Sylte,
Mari Gabrielsen,
kurt Kristiansen
:
Homology Modeling of Transporter Proteins
Methods in molecular biology 2023
ARKIV /
DOI
Linn Evenseth,
Riccardo Ocello,
Mari Gabrielsen,
Matteo Masetti,
Maurizio Recanatini,
Ingebrigt Sylte
et al.:
Exploring Conformational Dynamics of the Extracellular Venus flytrap Domain of the GABA B Receptor: A Path-Metadynamics Study
Journal of Chemical Information and Modeling 2020
ARKIV /
DOI
Linn Evenseth,
Mari Gabrielsen,
Ingebrigt Sylte
:
The GABAB Receptor—Structure, Ligand Binding and Drug Development
Linn Evenseth,
Dawid Warszycki,
Andrzej J Bojarski,
Mari Gabrielsen,
Ingebrigt Sylte
:
In Silico Methods for the Discovery of Orthosteric GABAB Receptor Compounds
Elvar Örn Viktorsson,
Mari Gabrielsen,
Nugalya Kumarachandran,
Ingebrigt Sylte,
Pål Rongved,
Ove Alexander Høgmoen Åstrand
et al.:
Regulation of liver X receptor target genes by 22-functionalized oxysterols. Synthesis, in silico and in vitro evaluations
Thibaud Freyd,
Dawid Warszycki,
Stefan Mordalski,
Andrzej J Bojarski,
Ingebrigt Sylte,
Mari Gabrielsen
:
Ligand-guided homology modelling of the GABA<sub>B2</sub> subunit of the GABA<sub>B</sub> receptor
Ove Alexander Høgmoen Åstrand,
Elvar Örn Viktorsson,
Aleksander Lim Kristensen,
Dag Ekeberg,
Hanne Røberg-Larsen,
Steven Ray Haakon Wilson
et al.:
Synthesis, in vitro and in vivo biological evaluation of new oxysterols as modulators of the liver X receptors
Journal of Steroid Biochemistry and Molecular Biology 2017
ARKIV /
DOI
Mari Gabrielsen,
Rafal Kurczab,
Agata Siwek,
Malgorzata Wolak,
Aina Westrheim Ravna,
kurt Kristiansen
et al.:
Identification of novel serotonin transporter compounds by virtual Screening
Journal of Chemical Information and Modeling 2014
ARKIV /
DOI
Irina Kufareva,
Vsevolod Katritch,
Thibaud Freyd,
Mari Gabrielsen,
kurt Kristiansen,
Ingebrigt Sylte
et al.:
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: Meeting new challenges
Yan Baglo,
Mari Gabrielsen,
Ingebrigt Sylte,
Odrun Arna Gederaas
:
Homology Modeling of Human -Butyric Acid Transporters and the Binding of Pro-drugs 5-Aminolevulinic Acid and Methyl Aminolevulinic Acid used in Photodynamic Therapy
Mari Gabrielsen,
Karol Wolosewicz,
Anna Zawadzka,
Jerzy Kossakowski,
Gabriel Nowak,
Malgorzata Wolak
et al.:
Synthesis, Antidepressant Evaluation and Docking Studies of Long-Chain Alkylnitroquipazines as Serotonin Transporter Inhibitors
Chemical Biology and Drug Design (CB&DD) 2013
DOI
Mari Gabrielsen,
aina westrheim Ravna,
kurt Kristiansen,
Ingebrigt Sylte
:
Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations
Journal of Molecular Modeling 2012
ARKIV /
DOI
Mari Gabrielsen,
Rafal Kurczab,
aina westrheim Ravna,
Irina Kufareva,
Ruben Abagyan,
Zdzislaw Chilmonczyk
et al.:
Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol
European Journal of Medicinal Chemistry 2012
DOI
Malgorzata Jaronczyk,
Karol Wolosewicz,
Mari Gabrielsen,
Gabriel Nowak,
Irina Kufareva,
Aleksander P Mazurek
et al.:
Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors
European Journal of Medicinal Chemistry 2012
DOI
Yan Baglo,
Mari Gabrielsen,
Ingebrigt Sylte,
Odrun Arna Gederaas
:
Homology Modeling of Human -Butyric Acid Transporters and the Binding of Pro-drugs 5-Aminolevulinic Acid and Methyl Aminolevulinic Acid used in Photodynamic Therapy
2013
Mari Gabrielsen,
Ingebrigt Sylte,
Svein G. Dahl,
aina westrheim Ravna
:
A short update on the structure of drug binding sites on neurotransmitter transporters
BMC Research Notes 2011
DOI
Mari Gabrielsen
:
Docking of substrates and inhibitors into the substrate binding site of two serotonin transporter models
2011
Mari Gabrielsen
:
Structure, function and inhibition of the serotonin transporter studied by molecular docking, -dynamics and virtual screening
UiT Norges arktiske universitet 2011
Mari Gabrielsen
:
The search for new SERT inhibitors, possible antidepressant drugs
2011